Case Updates
The Hon. Arthur J. Tarnow entered a final judgment in the securities class action lawsuit Dougherty v. Esperion Therapeutics, Case No. 2:16-cv-10089, approving Lead Plaintiffs’ $18.25 million recovery.
The Court approved the settlement of the stockholder derivative action brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties.
The Hon. Susan Illston approved the selection of KSF as lead counsel for the putative class in Meysam Moradpour v. Velodyne Lidar Inc., et. al.
The Hon. Arthur J. Tarnow entered an Order preliminarily approving a $18,250,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Esperion common stock between August 18, 2015 and September 28, 2015.
On April 22, 2021, the Hon. Janis L. Sammartino entered an Order preliminarily approving a $4,800,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Orexigen publicly-traded securitiesbetween March 3, 2015 and May 12, 2015.
On May 19, 2021, the Hon. Cormac J. Carney approved the selection of KSF as Lead Counsel for the putative class in Sam Farrar v. Workhorse Group, Inc. et al.,
Final judgment and order in the consolidated Health Insurance Innovations Securities Litigation was entered approving a $2.8 million recovery for investors.
KSF’s stockholder derivative action was brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties. On December 17, 2020, plaintiffs were able to secure a settlement providing that Twitter’s board of directors will pay $38 million in cash to Twitter and $8.75 million in attorney fees and court costs.
The Hon. Thomas P. Barber, United States District Court Judge for the Middle District of Florida, entered an Order preliminarily approving a $2,800,000 class action settlement on behalf of all Persons or entities who purchased or otherwise acquired HIIQ publicly-traded securities between August 4, 2017 and September 11, 2017, inclusive.
On November 29, 2020, Vice Chancellor Joseph R. Slights III of the Delaware Court of Chancery granted final approval to the shareholder derivative settlement in In re Fitbit, Inc. Stockholder Derivative Litigation.
The Hon. Arthur J. Tarnow issued an Order granting Plaintiffs’ motion for class certification in its entirety in Dougherty v. Esperion Therapeutics, Inc.
The Hon. J. Paul Oetken, United States District Court Judge for the Southern District of New York, entered an Order preliminarily approving a $1,600,000 class action settlement in Intellipharmaceutics Securities Litigation
The Hon. Kathleen Kay of the Western District of Louisiana approved the selection of KSF as Lead Counsel for the putative class in Welch v. Meaux, et al.
The Hon. Lucy H. Koh of the Northern District of California approved the selection of KSF as Lead Counsel for the putative class in In Re Cloudera Securities Litigation.
The Hon. Lucy H. Koh of the Northern District of California approved the selection of KSF as Lead Counsel for the putative class in Ikeda v. Baidu, Inc.
A three-judge panel for the Second Circuit Court of Appeals vacated in-part the dismissal order of Hon. William H. Pauley III, reviving investors’ Exchange Act claims against NewLink Genetics Corp.
The Honorable R. Steven Whalen certified a class of shareholders in Dougherty v. Esperion Therapeutics, Inc. et al, No. 2:16-cv-10089, a securities fraud class action involving Defendants’ materially misleading statements and omissions concerning a cardiovascular outcomes trial for the Company’s lead drug candidate.
The Hon. William J. Martini, United States District Judge for the District of New Jersey, entered an Order denying Defendants’ motion to dismiss against Honeywell, and individual defendants Darius Adamczyk, and Thomas A. Szlosek.
The Hon. Nicholas G. Garaufis, United States District Court Judge for the Eastern District of New York, entered an Order denying, in part, defendants’ motion to dismiss in Oliver, et al. v. American Express Company, et al.
KSF approved as Co-Lead Counsel for the Class in Bellingham v. Qudian Inc. et al. Plaintiffs allege that Defendants made materially false and misleading statements and failed to disclose material information regarding the negative effect developments in China’s regulatory environment had on Qudian’s business and operations.